Hot or Not, Stock Market Edition: 06/12/2025

• HOT: Eli Lilly and Company (LLY) continues to ride high on blockbuster weight-loss drugs; what’s behind recent double-digit gains for Casey’s General Stores (CASY)?
• NOT: The J.M. Smucker Company (SJM) finds itself in a jam; unpacking Apple’s (AAPL) rough year so far.

P.S. For more stocks making moves, check out our new Zen Ratings Upgrades & Downgrades screener.

A note from our sponsors...
The gold income breakthrough most investors are missing  

It's not a mining stock. It's not an option trade. And it's not physical gold you have to store in a vault. A quiet little fund - trading for just $15 - that's been delivering up to $1,152 a month to regular investors. It's a smarter, faster, and easier way to ride gold's surge and get paid monthly while you do it.   

Click here to discover the gold income breakthrough most investors are missing.

🔥 HOT: Shares of Casey’s General Stores (NASDAQ: CASY) gained 11.5% on Tuesday after the company reported solid earnings for the fiscal fourth quarter and issued strong guidance for the upcoming fiscal year. The company’s EPS for the previous quarter was $2.63, about 35% higher than Wall Street’s projection of $1.94. The report also showed that same-store sales grew by 1.7% year-over-year, and Casey’s expects it to increase another 2% to 5% in 2025. Our analysis gives Casey’s a B rating in Growth and an overall Zen Rating of B.

🥶 NOT: Shares of The J.M. Smucker Company (NYSE: SJM) fell off a cliff on Tuesday, dropping by 15.6% after a disappointing earnings report. The company’s first-quarter results were fine, beating Wall Street’s estimates by around 3.0%, but its forward guidance sent investors running for the hills. The company announced that it expects its full-year adjusted profit to be between $8.50 and $9.50 per share, a far cry from the $10.27 that Wall Street expected to see. SJM had been trading mostly flat before Tuesday’s crash, leaving it down 15.1% YTD. Our research gives SJM C ratings for all metrics besides Sentiment, which gets a modest B rating. Overall, we give SJM a C Zen Rating and a Hold recommendation.

🔥 HOT: Eli Lilly and Company (NYSE: LLY) gained 4.4% on Tuesday after the company announced a deal with Camurus to develop a new delivery system for weight-loss drugs. The company is also sitting on a potential $725 million sales boost from Mounjaro, an injectable drug that helps lower A1C levels and promote weight loss in people with diabetes. Our research gives LLY a B rating in growth, reflecting the potential the company has if Mounjaro gets enough attention from people looking for access to a weight loss injectable with a cash payment option. We tend to play it safe with pharmaceutical stocks, but LLY’s Growth potential and current Value give it a B Zen Rating and a Buy recommendation.

🥶 NOT: It’s been a rough year for Apple (NASDAQ: AAPL) so far, with the company’s stock down 18.6% YTD as of Tuesday’s close. Between the comments about Apple-specific levies from the current administration and a disappointing first day of its Worldwide Developers Conference, Apple is falling well short of other tech stocks. Our metrics have AAPL on shaky ground, with D ratings in Growth and Sentiment and C ratings in Value, Momentum, and Safety. The only saving grace for AAPL is that the company’s Financials (A rating) are as solid as ever. Apple is a traditionally cautious company, so its slow playing of AI integration in its products may not be a long-term concern. Still, given its current position, we give AAPL a C Zen Rating and a Hold recommendation.

What to Do Next?

• 200 Stocks to Sell Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.